Notable Analyst Rating Changes 9/24: MTH, NSM, WFC, AIMC, CPN, SHFL Higher; LLL, AZN, VIP, ANN, KGC, UFS Downgraded
More News related to AIMC
- Altra Holdings (AIMC) Closes $210M Senior Notes Offering; Enters Into Revolving Credit Facility; Subsidiary Tenders $167.9M of Senior Notes
- Altra Holdings, Inc. Announces Closing of $210.0 Million 8 1/8% Senior Secured Notes Due 2016, Entry Into New Senior Secured Revolving Credit Facility, and Results to Date of Tender Offer by Subsidiar
- Altra Holdings (AIMC) Announces Pricing of Senior Secured Notes of 98.691% of Face Value; Aggregate Principal Amount of $210M
- Altra Holdings, Inc. Announces Pricing of $210 Million Note Offering of Senior Secured Notes Due 2016
- Altra Holdings, Inc. Announces $200 Million Note Offering of Senior Secured Notes Due 2016
More News related to ANN
- AnnTaylor (ANN) Shares Rallying as Analyst Sees Attractive Entry Point, Upgrades to Overweight
- Auriga Reiterates a 'Buy' on Ann Taylor Stores (ANN); Buying for Positive Comps in FY10
- Ann Taylor Stores Corp. Returns To St. Jude Children's Research Hospital's Thanks and Giving Campaign(R) For The Third Year
- Thomas Weisel Upgrades AnnTaylor (ANN) to Overweight
- AnnTaylor (ANN) Posts Q3 EPS of $0.20 Ex-Items, Tops by 13c; Guides Q409 Sales
More News related to AZN
- U.S. Court of Appeals Upholds AstraZeneca AWP Settlement
- AstraZeneca and the Philadelphia Department of Public Health Provide Free Medicines to Pennsylvania's Uninsured
- AstraZeneca (AZN) Submits NDA to U.S. FDA for Ticagrelor
- AstraZeneca Submits US New Drug Application for Ticagrelor (BRILINTA(TM)), an Investigational Antiplatelet Agent
- Results From Two Phase II Trials Add to Understanding of Ticagrelor (BRILINTA(TM)) and How it Works in the Body
More News related to Special Reports
- Top 10 News Items 11/23-11/27: Dubai Debt Fallout; Gold; GDP Revised Lower; Diedrich Coffee Bidding War
- Trading Radar for 11/30: Inergy Holdings (NRGP), Golar (GLNG), Omnivision (OVTI), Knightsbridge (VLCCF) Report
- Notable Mergers and Acquisitions of the Day for 11/27: F, S/IPCS, STAR/CSCO, HRAY
- Notable Analyst Rating Changes 11/27: TIF, QLTI Upgraded; FSNM, RGFC Downgraded
- Notable ETF Movers *Special Dubai World Edition* 11/27: UUP Higher; GAF, EEM, FXI, XLF Lower
UPGRADES:
Goldman upgraded Meritage (NYSE: MTH) from Neutral to Conviction Buy with a $22 price target.
Citi upgrades National Semiconductor (NYSE: NSM) from Hold to Buy. Click here for some more color on the upgrade.
Atlantic Equities upgrades Wells Fargo (NYSE: WFC) from Underweight to Neutral.
Bank of America upgrades Altra Holdings (Nasdaq: AIMC) from Neutral to Buy. Price target increased from $6 to $13.
Citi upgrades Calpine (NYSE: CPN) from Hold to Buy. Price target increased from $13 to $16.50.
Roth Capital upgrades Shuffle Master (Nasdaq: SHFL) from Hold to Buy. Price target increased from $8 to $11.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
JPMorgan downgrades L-3 Communications (NYSE: LLL) from Overweight to Neutral.
Goldman Sachs downgrades AstraZeneca plc (NYSE: AZN) from Neutral to Sell, saying Crestor litigation is likely to weigh on performance.
Deutsche Bank downgrades VimpelCom (NYSE: VIP) from Buy to Hold. Price target $18. Click here for the full report.
Goldman Sachs downgrades AnnTaylor Stores Corp. (NYSE: ANN) from Buy to Neutral, citing a more balanced risk/reward. The firm notes shares have almost doubled since two months ago and risks still remain. The firm has a $17 price target on ANN.
Thomas Weisel downgrades Kinross Gold (NYSE: KGC) from Overweight to Marketweight.
Deutsche Bank downgrades Domtar (NYSE: UFS) from Buy to Hold. Price target raised to $40. Here is the full report.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Oppenheimer initiates coverage on Fuqi International (Nasdaq: FUQI) with an Outperform rating. Price target $38.
FTN Equity initiates coverage on Genzyme (Nasdaq: GENZ) with a Neutral rating. Price target $64.
Brean Murray initiates coverage on Phillips-Van Heusen (NYSE: PVH) with a Buy. Price target $51. Click here for the full report.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
-0.63
+0.06Related Entities
- Deutsche Bank
- Brean Murray Carret & Co.
- JPMorgan
- Citi
- Banc of America
- Roth Capital
- Thomas Weisel Partners Group
- Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
